A Phase 1/2a Study Evaluating Allocetra-OTS as Monotherapy or in Combination With Anti-PD-1 Therapy for the Treatment of Advanced Solid Tumor Malignancy
Condition(s):Solid Tumor; Peritoneal Metastases; Peritoneal CancerLast Updated:June 22, 2023Recruiting